# Copart Inc: financial statements, quarterly

CPRT · Nasdaq · CIK 900075 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jul 31

Pages: [Overview](/companies/cprt.md) · [Financials](/companies/cprt/financials.md) · [Filings](/companies/cprt/filings.md) · [Insiders](/companies/cprt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cprt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,020](/filings/0000900075-24-000030.md) | [1,020](/filings/0000900075-25-000007.md) | [1,127](/filings/0001628280-25-029093.md) | [1,069 d](/filings/0001193125-26-405731.md) | [1,147](/filings/0001193125-25-291660.md) | [1,163](/filings/0001193125-26-088593.md) | [1,212](/filings/0001193125-26-245578.md) | [1,125 d](/filings/0001193125-26-405731.md) | [1,155](/filings/0001193125-25-291660.md) | [1,122](/filings/0001193125-26-088593.md) | [1,237](/filings/0001193125-26-245578.md) | [1,152 d](/filings/0001193125-26-405731.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [395](/filings/0000900075-24-000030.md) | [380](/filings/0000900075-25-000007.md) | [437](/filings/0001628280-25-029093.md) | [360 d](/filings/0001193125-26-405731.md) | [406](/filings/0001193125-25-291660.md) | [426](/filings/0001193125-26-088593.md) | [452](/filings/0001193125-26-245578.md) | [413 d](/filings/0001193125-26-405731.md) | [431](/filings/0001193125-25-291660.md) | [389](/filings/0001193125-26-088593.md) | [464](/filings/0001193125-26-245578.md) | [369 d](/filings/0001193125-26-405731.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [90.8](/filings/0000900075-24-000030.md) | [85.2](/filings/0000900075-25-000007.md) | [90.0](/filings/0001628280-25-029093.md) | [86.2 d](/filings/0001193125-26-405731.md) | [90.1](/filings/0001193125-25-291660.md) | [76.5](/filings/0001193125-26-088593.md) | [97.5](/filings/0001193125-26-245578.md) | [83.1 d](/filings/0001193125-26-405731.md) | [84.9](/filings/0001193125-25-291660.md) | [91.1](/filings/0001193125-26-088593.md) | [101](/filings/0001193125-26-245578.md) | [77.9 d](/filings/0001193125-26-405731.md) |
| Net income | $m | [333](/filings/0000900075-24-000030.md) | [326](/filings/0000900075-25-000007.md) | [382](/filings/0001628280-25-029093.md) | [323 d](/filings/0001193125-26-405731.md) | [362](/filings/0001193125-25-291660.md) | [387](/filings/0001193125-26-088593.md) | [407](/filings/0001193125-26-245578.md) | [396 d](/filings/0001193125-26-405731.md) | [404](/filings/0001193125-25-291660.md) | [351](/filings/0001193125-26-088593.md) | [402](/filings/0001193125-26-245578.md) | [327 d](/filings/0001193125-26-405731.md) |
| Diluted EPS | $ per share | [0.34](/filings/0000900075-24-000030.md) | [0.33](/filings/0000900075-25-000007.md) | [0.39](/filings/0001628280-25-029093.md) | not reported | [0.37](/filings/0001193125-25-291660.md) | [0.40](/filings/0001193125-26-088593.md) | [0.42](/filings/0001193125-26-245578.md) | not reported | [0.41](/filings/0001193125-25-291660.md) | [0.36](/filings/0001193125-26-088593.md) | [0.43](/filings/0001193125-26-245578.md) | not reported |
| Basic EPS | $ per share | [0.35](/filings/0000900075-24-000030.md) | [0.34](/filings/0000900075-25-000007.md) | [0.40](/filings/0001628280-25-029093.md) | not reported | [0.38](/filings/0001193125-25-291660.md) | [0.40](/filings/0001193125-26-088593.md) | [0.42](/filings/0001193125-26-245578.md) | not reported | [0.42](/filings/0001193125-25-291660.md) | [0.36](/filings/0001193125-26-088593.md) | [0.43](/filings/0001193125-26-245578.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $bn | [3.6](/filings/0000900075-23-000043.md) | [3.7](/filings/0000900075-24-000007.md) | [4.1](/filings/0000900075-24-000014.md) | [4.4](/filings/0001628280-25-042946.md) | [4.7](/filings/0000900075-24-000030.md) | [5.0](/filings/0000900075-25-000007.md) | [5.4](/filings/0001628280-25-029093.md) | [5.8](/filings/0001193125-26-405731.md) | [6.2](/filings/0001193125-25-291660.md) | [6.2](/filings/0001193125-26-088593.md) | [5.2](/filings/0001193125-26-245578.md) | [5.6](/filings/0001193125-26-405731.md) |
| Total assets | $bn | [7.3](/filings/0000900075-23-000043.md) | [7.6](/filings/0000900075-24-000007.md) | [8.0](/filings/0000900075-24-000014.md) | [8.4](/filings/0001193125-26-405731.md) | [8.9](/filings/0000900075-24-000030.md) | [9.2](/filings/0000900075-25-000007.md) | [9.7](/filings/0001628280-25-029093.md) | [10.1](/filings/0001193125-26-405731.md) | [10.6](/filings/0001193125-25-291660.md) | [10.6](/filings/0001193125-26-088593.md) | [9.6](/filings/0001193125-26-245578.md) | [10.0](/filings/0001193125-26-405731.md) |
| Current liabilities | $bn | [0.6](/filings/0000900075-23-000043.md) | [0.5](/filings/0000900075-24-000007.md) | [0.6](/filings/0000900075-24-000014.md) | [0.6](/filings/0001628280-25-042946.md) | [0.7](/filings/0000900075-24-000030.md) | [0.6](/filings/0000900075-25-000007.md) | [0.7](/filings/0001628280-25-029093.md) | [0.7](/filings/0001193125-26-405731.md) | [0.8](/filings/0001193125-25-291660.md) | [0.6](/filings/0001193125-26-088593.md) | [0.7](/filings/0001193125-26-245578.md) | [0.7](/filings/0001193125-26-405731.md) |
| Total liabilities | $bn | [0.9](/filings/0000900075-23-000043.md) | [0.8](/filings/0000900075-24-000007.md) | [0.8](/filings/0000900075-24-000014.md) | [0.9](/filings/0001628280-25-042946.md) | [0.9](/filings/0000900075-24-000030.md) | [0.9](/filings/0000900075-25-000007.md) | [0.9](/filings/0001628280-25-029093.md) | [0.9](/filings/0001193125-26-405731.md) | [1.0](/filings/0001193125-25-291660.md) | [0.8](/filings/0001193125-26-088593.md) | [0.9](/filings/0001193125-26-245578.md) | [0.9](/filings/0001193125-26-405731.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [6.4](/filings/0000900075-23-000043.md) | [6.8](/filings/0000900075-24-000007.md) | [7.2](/filings/0000900075-24-000014.md) | [7.5](/filings/0001628280-25-042946.md) | [7.9](/filings/0000900075-24-000030.md) | [8.3](/filings/0000900075-25-000007.md) | [8.8](/filings/0001628280-25-029093.md) | [9.2](/filings/0001193125-26-405731.md) | [9.6](/filings/0001193125-25-291660.md) | [9.8](/filings/0001193125-26-088593.md) | [8.8](/filings/0001193125-26-245578.md) | [9.1](/filings/0001193125-26-405731.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [375](/filings/0000900075-24-000030.md) | [162 d](/filings/0000900075-25-000007.md) | [496 d](/filings/0001628280-25-029093.md) | [439 d](/filings/0001193125-26-405731.md) | [482](/filings/0001193125-25-291660.md) | [178 d](/filings/0001193125-26-088593.md) | [701 d](/filings/0001193125-26-245578.md) | [438 d](/filings/0001193125-26-405731.md) | [535](/filings/0001193125-25-291660.md) | [128 d](/filings/0001193125-26-088593.md) | [584 d](/filings/0001193125-26-245578.md) | [358 d](/filings/0001193125-26-405731.md) |
| Capital expenditure | $m | [162](/filings/0000900075-24-000030.md) | [123](/filings/0000900075-25-000007.md) | [87.8](/filings/0001628280-25-029093.md) | [138 d](/filings/0001193125-26-405731.md) | [237](/filings/0001193125-25-291660.md) | [174](/filings/0001193125-26-088593.md) | [70.5](/filings/0001628280-25-029093.md) | [87.6 d](/filings/0001193125-26-405731.md) | [108](/filings/0001193125-25-291660.md) | [69.6](/filings/0001193125-26-088593.md) | [80.9 d](/filings/0001193125-26-245578.md) | [78.8 d](/filings/0001193125-26-405731.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1,414 d](/filings/0001193125-26-245578.md) | [0.0 d](/filings/0001193125-26-405731.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-10-31) | Q2 FY2023 (2023-01-31) | Q3 FY2023 (2023-04-30) | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [964](/filings/0000900075-23-000043.md) | [965](/filings/0000900075-24-000007.md) | [967](/filings/0000900075-24-000014.md) | [972](/filings/0000900075-24-000030.md) | [975](/filings/0000900075-25-000007.md) | [976](/filings/0001628280-25-029093.md) | [977](/filings/0001193125-25-291660.md) | [978](/filings/0001193125-26-088593.md) | [978](/filings/0001193125-26-245578.md) | [977](/filings/0001193125-25-291660.md) | [975](/filings/0001193125-26-088593.md) | [943](/filings/0001193125-26-245578.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 926,330,452 at 2026-09-25, from the cover of the [10-K filed 2026-09-29](/filings/0001193125-26-405731.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.